Company profile for Captor Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Captor Therapeutics is a biopharmaceutical company focused on development of protein degradation drugs for cancer and autoimmune diseases, which have limited or no known treatment options. Targeted Protein Degradation (TPD) combats the therapeutic limits of small molecules with overcoming drug resistance and uncoupling their pharmacokinetics from pharmacodynamics. Breakthrough TPD technology allows degradation of virtually an...
Captor Therapeutics is a biopharmaceutical company focused on development of protein degradation drugs for cancer and autoimmune diseases, which have limited or no known treatment options. Targeted Protein Degradation (TPD) combats the therapeutic limits of small molecules with overcoming drug resistance and uncoupling their pharmacokinetics from pharmacodynamics. Breakthrough TPD technology allows degradation of virtually any intracellular protein including the so-called "undruggable proteome".

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Poland
Address
Address
Duńska 11, Wrocław, dolnośląskie 54-427
Telephone
Telephone
+48 537 869 089
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2023/05/30/2678304/0/en/Captor-Therapeutics-Publishes-Q1-2023-Financial-Results.html

GLOBENEWSWIRE
30 May 2023

https://www.globenewswire.com/news-release/2023/03/28/2635336/0/en/Captor-Therapeutics-Discloses-Molecular-Targets-of-Pipeline-s-Lead-Assets-and-Invites-Stakeholders-to-Webcast.html

GLOBENEWSWIRE
28 Mar 2023

https://www.globenewswire.com/news-release/2023/03/07/2621687/0/en/Captor-Therapeutics-Announces-Three-Year-Strategic-Objectives.html

GLOBENEWSWIRE
07 Mar 2023

https://www.globenewswire.com/news-release/2022/11/25/2562604/0/en/Captor-Therapeutics-Reports-Q3-2022-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
25 Nov 2022

https://www.globenewswire.com/news-release/2022/11/14/2554821/0/en/Ono-Pharmaceutical-and-Captor-Therapeutics-Announce-Drug-Discovery-Collaboration-to-Develop-Small-Molecule-Protein-Degraders-for-the-Treatment-of-Neurodegenerative-Diseases.html

GLOBENEWSWIRE
14 Nov 2022

https://www.captortherapeutics.com/news/65/captor-therapeutics-announces-participation-in-upcoming-scientific-investor-and-partnering-conferences-in-october-2022

PRESS RELEASE
09 Sep 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty